Want to join the conversation?
$DHR 2Q15 Q&A: Steve of JPMorgan: Anything fundamentally within the businesses from an organic perspective? Dan, CFO: As we see EMV regulations continue to come closer, those dynamics will continue to improve GVR. GVR was a little lighter in the 2Q, but good year-to-date, but look to see that accelerate in the back half of 2015 & clearly in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?